Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027
Market Analysis and Insights: Global Blood Plasma Fractionation Market
In 2020, the global Blood Plasma Fractionation market size was US$ 26384 million and it is expected to reach US$ 44034 million by the end of 2027, with a CAGR of 7.63% between 2021 and 2027.
Global Blood Plasma Fractionation Scope and Market Size
The global Blood Plasma Fractionation market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
South America
Brazil
Middle East & Africa
Middle East
Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook